ProPhase Labs, Inc. (PRPH) Insider Trading Disclosures
ProPhase Labs, Inc. (PRPH) is a publicly traded company on the OTC, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: PRPH
CIK: 868278
Exchange: OTC
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Fruci & Associates II, PLLC
Auditor SinceSince 12/31/2024 12:00:00 AM
Lead Engagement PartnerKory Kolterman
Audit LocationSpokane, Washington, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 10-Q | 2026-08-19 | 2026-06-30 | 10-Q | 0001493152-26-039224 | View SEC Doc Filr Page |
| NT 10-Q | 2026-08-14 | 2026-06-30 | NT 10-Q | 0001493152-26-038433 | View SEC Doc Filr Page |
| 8-K | 2026-08-06 | 2026-07-31 | 8-K | 0001493152-26-036383 | View SEC Doc Filr Page |
| 10-Q/A | 2026-07-09 | 2026-03-31 | 10-Q/A | 0001493152-26-032658 | View SEC Doc Filr Page |
| 10-Q/A | 2026-07-07 | 2026-03-31 | 10-Q/A | 0001493152-26-032269 | View SEC Doc Filr Page |
| 10-Q | 2026-06-30 | 2026-03-31 | 10-Q | 0001493152-26-031301 | View SEC Doc Filr Page |
| 10-K | 2026-06-01 | 2025-12-31 | 10-K | 0000868278-26-000005 | View SEC Doc Filr Page |
| NT 10-Q | 2026-05-15 | 2026-03-31 | NT 10-Q | 0001493152-26-023848 | View SEC Doc Filr Page |
| NT 10-K | 2026-03-27 | 2025-12-31 | NT 10-K | 0001493152-26-013251 | View SEC Doc Filr Page |
| 8-K | 2026-02-13 | 2026-02-03 | 8-K | 0001493152-26-006784 | View SEC Doc Filr Page |
| 8-K | 2026-02-13 | 2026-02-02 | 8-K | 0001493152-26-006785 | View SEC Doc Filr Page |
| 8-K | 2026-01-27 | 2026-01-26 | 8-K | 0001493152-26-003724 | View SEC Doc Filr Page |
| 8-K | 2026-01-23 | 2026-01-22 | 8-K | 0001493152-26-003460 | View SEC Doc Filr Page |
| 8-K | 2026-01-23 | 2026-01-23 | 8-K | 0001493152-26-003456 | View SEC Doc Filr Page |
| 25-NSE | 2026-01-23 | — | 25-NSE Filing | 0001354457-26-000084 | View SEC Doc Filr Page |
| 8-K | 2026-01-09 | 2026-01-09 | 8-K | 0001493152-26-001143 | View SEC Doc Filr Page |
| 8-K | 2026-01-09 | 2026-01-09 | 8-K | 0001493152-26-001134 | View SEC Doc Filr Page |
| 8-K | 2026-01-02 | 2025-12-29 | 8-K | 0001493152-26-000175 | View SEC Doc Filr Page |
| 424B5 | 2025-12-29 | — | 424B5 | 0001493152-25-029417 | View SEC Doc Filr Page |
| 8-K | 2025-12-19 | 2025-12-19 | 8-K | 0001493152-25-028537 | View SEC Doc Filr Page |
| 8-K | 2025-12-19 | 2025-12-12 | 8-K | 0001493152-25-028483 | View SEC Doc Filr Page |
| 424B5 | 2025-12-19 | — | 424B5 | 0001493152-25-028480 | View SEC Doc Filr Page |
| 8-K/A | 2025-12-18 | 2025-12-10 | 8-K/A | 0001493152-25-028317 | View SEC Doc Filr Page |
| 8-K/A | 2025-12-12 | 2025-12-10 | 8-K/A | 0001493152-25-027399 | View SEC Doc Filr Page |
| 8-K | 2025-12-12 | 2025-12-10 | 8-K | 0001493152-25-027317 | View SEC Doc Filr Page |